U.S. Food And Drug Administration (FDA)

Pain management for medication abortion, support for eight years of use for a LNG 52mg IUD (Mirena and Liletta), IUD placement within 48 hours after medication abortion, and more.

Management of retained products of conception and a comparison of buccal and vaginal misoprostol for medication abortion, contraceptive values and preferences of adolescents and young adults, and more.

Effective emergency contraception for individuals with obesity, the need for a reproductive justice lens in contraceptive counseling, a new treatment for bacterial vaginosis, and more.

A quick guide to the five IUDs currently available in the US and tips for counseling your patients on their IUD options.

Zinc supplements to help clear cervical HPV, unmet needs for reproductive health care in primary care settings, distance related barriers to abortion access, and more.

A quick reference guide and resources for providers on prescribing and managing pre-exposure prophylaxis (PrEP) for prevention of HIV

A quick reference guide and resources for providers on prescribing and managing nonoccupational post-exposure prophylaxis (nPEP) for prevention of HIV.

An analysis of the necessity for escort requirements in abortion care, tamoxifen to help with bleeding for implant users, depression and its possible correlation with unintended pregnancy, methods for remote gestational age assessment, and more.